<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> and the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> in <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) patients (defined as <z:e sem="disease" ids="C0409983" disease_type="Disease or Syndrome" abbrv="">secondary antiphospholipid syndrome</z:e>) are characterized by the presence of anticardiolipin antibodies, <z:mp ids='MP_0005048'>thrombosis</z:mp>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, and recurrent fetal loss </plain></SENT>
<SENT sid="1" pm="."><plain>To determine the role of anticardiolipin antibodies in the pathogenesis of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, monoclonal anticardiolipin antibodies were derived from mice in which experimental <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> was induced by a murine monoclonal anti-16/6 Id antibody </plain></SENT>
<SENT sid="2" pm="."><plain>Two murine monoclonal anticardiolipin antibodies (2C4C2, 2C4D1) were generated and characterized </plain></SENT>
<SENT sid="3" pm="."><plain>The 2C4C2, but not the 2C4D1, monoclonal antibody demonstrated remarkable <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> activity </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, these murine anticardiolipin monoclonal antibodies appear to recognize antigenic <z:chebi fb="0" ids="53000">epitopes</z:chebi> similar to those recognized by anticardiolipin antibodies found in sera of SLE patients </plain></SENT>
<SENT sid="5" pm="."><plain>The monoclonal anticardiolipin antibody 2C4C2 was injected into naive female mice </plain></SENT>
<SENT sid="6" pm="."><plain>Following immunization, the mice developed high titers of autoantibodies reacting with <z:chebi fb="0" ids="28494">cardiolipin</z:chebi>, DNA, nuclear extract, 16/6 and anti-16/6 Id, and anticardiolipin antibodies </plain></SENT>
<SENT sid="7" pm="."><plain>As early as 8 weeks after immunization these mice exhibited significant <z:hpo ids='HP_0001882'>leukopenia</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, and <z:hpo ids='HP_0000093'>proteinuria</z:hpo> with immune complex <z:hpo ids='HP_0000099'>glomerulonephritis</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, mating of 2C4C2-injected mice with allogenic males resulted in low pregnancy rates and a low number of fetuses with a high percentage of fetal loss </plain></SENT>
<SENT sid="9" pm="."><plain>These studies provide a new experimental model for <z:e sem="disease" ids="C0409983" disease_type="Disease or Syndrome" abbrv="">secondary antiphospholipid syndrome</z:e> demonstrating the role of anticardiolipin antibodies in the pathogenesis of this syndrome </plain></SENT>
</text></document>